Harvard Pilgrim Health Care Home
  Learn more.
  Sign up for HPHConnect.
Medical Management
For Your Patient
News Center
Network Matters
Newsletter Archives
Newsletter Registration
Office Support
Provider Manual
Medicare Advantage
Research & Teaching
Resources & Links
Print    Text Size

Network Matters
News and Information for the
Harvard Pilgrim Health Care Network

May 2017

Fecal Microbiota Transplantation Medical Policy Updated

Harvard Pilgrim is updating our Fecal Microbiota Transplantation Medical Policy to clarify coverage criteria and add an additional CPT code as eligible for coverage. Harvard Pilgrim considers fecal microbiota transplantation medically necessary when healthy donor stool is available for transplant, and all of the following are met:  

  • Documentation confirms Clostridium difficile infection by a positive stool test
  • At least three or more episodes of recurrent Clostridium difficile infections 
  • Documentation confirms episodes are refractory to at least two full courses of antibiotic regimens (e.g. metronidazole, fidaxomicin, vancomycin)

In addition, effective for dates of service beginning June 1, 2017, we are adding the following CPT code to the policy as eligible for coverage:

  • 44705 – Preparation of fecal microbiota for instillation, including assessment of donor specimen

Prior authorization is not required. Please refer to the updated Fecal Microbiota Transplantation Medical Policy for complete coverage criteria.

Email this article to a colleague   

Network Matters Archives

Download printer-friendly version


GIC Product Updates Effective July 1


Medical Drug Prior Authorization Program with CVS Health–NovoLogix

Reminder: CVS Specialty is New Preferred Specialty Pharmacy

Update to ExMI Therapy for Urinary Incontinence Medical Policy

Update to Infliximab Medical Review Criteria

Fecal Microbiota Transplantation Medical Policy Updated

Reducing Preventable Readmissions in the Medicare Advantage Population

Non-Medication Alternative Treatments for Chronic Pain

ACA Risk Adjustment Data Validation: Medical Chart Requests

Robust Discussion at Massachusetts Medical Directors’ Meeting


2017 Home Care Seasonal Flu Vaccine Fee Schedule


Eric H. Schultz,
President and Chief Executive Officer

Robert Farias,
Vice President, Network Services

Annmarie Dadoly,

Joseph O'Riordan,

Kristin Edmonston,
Production Coordinator